Cargando...

Long Term Result of Intravitreal Bevacizumab in a Patient Newly Transformed to Proliferative Macular Telangiectasia Type 2

The clinical and imaging findings and therapeutic outcomes of intravitreal bevacizumab injection in a patient with macular telangiectasia type 2 are described. The patient first presented with the non-proliferative stage of the disease for 4 months, then the disease transformed to the proliferative...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ozkaya, Abdullah, Alkin, Zeynep, Karakucuk, Yalcin, Yazici, Ahmet Taylan, Demirok, Ahmet
Formato: Artigo
Idioma:Inglês
Publicado: Medknow Publications & Media Pvt Ltd 2013
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3841959/
https://ncbi.nlm.nih.gov/pubmed/24339691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-9233.120005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!